Transoral ultrasound added to the physical examination for suspected peritonsillar abscess – A research protocol for a multicenter cluster randomized trial
INTRODUCTION: Peritonsillar abscess (PTA) is one of the most frequent deep neck infections that requires urgent evaluation. Distinguishing PTA from peritonsillar cellulitis (PTC) on physical examination alone is challenging, yet clinically important, as PTA is treated with surgical drainage, whereas PTC is managed with antibiotics alone. Transoral ultrasound is a promising diagnostic adjunct that may improve clinicians' ability to differentiate between these conditions, but current evidence supporting its routine use remains limited. OBJECTIVE: This clinical trial examines whether the use of transoral ultrasound, as an extension of the clinical examination, improves diagnostic accuracy and treatment in patients suspected of a peritonsillar abscess. METHODS: A prospective, cluster-randomized, multi-center trial is enrolling patients referred to four Danish ear, nose, and throat (ENT) departments with suspected peritonsillar abscess. Participants are randomized weekly to either clinical examination alone or clinical examination with surgeon-performed transoral ultrasound. All patients receive standard treatment of a PTA if it is suspected, including surgical intervention (needle aspiration or tonsillectomy) and antibiotics. Primary outcomes include diagnostic accuracy (sensitivity, specificity, and overall accuracy). We will include 368 patients according to the power analysis. CONCLUSIONS: This multicenter randomized trial will be the largest to explore the potential benefits of integrating transoral ultrasound into the physical examination of patients suspected of peritonsillar abscesses. When introducing a new diagnostic tool, there is always a risk that false-positive or false-negative findings can delay appropriate treatment or prompt unnecessary procedures. As transoral ultrasound is also associated with increased ultrasound equipment costs, prolonged consultation time, and greater workflow complexity, it is important to assess its impact on patient outcomes before incorporating it into clinical guidelines. This trial is powered to determine whether the potential benefits of a transoral ultrasound of all patients with a suspected PTA outweigh the challenges.
Authors
- Amalie Hartvig Pall (ORCID: https://orcid.org/0000-0002-4389-2040)
- Kasper Wennervaldt (ORCID: https://orcid.org/0000-0003-4845-0353)
- Morten Matthiesen Bach Damm (ORCID: https://orcid.org/0000-0003-1282-3349)
- Martin Garset‐Zamani (ORCID: https://orcid.org/0000-0003-3857-8003)
- Michael Frantz Howitz (ORCID: https://orcid.org/0000-0001-8061-6523)
- Tobias Todsen (ORCID: https://orcid.org/0000-0003-3267-3560)
- Thomas Kjærgaard (ORCID: https://orcid.org/0000-0002-5090-4812)
- Gitte Bjørn Hvilsom (ORCID: https://orcid.org/0000-0001-9239-3208)
- Trine Nybo Ranneries (ORCID: https://orcid.org/0009-0007-0099-2272)
Institutions
- University of Copenhagen (DK)
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- Rigshospitalet (DK)
- Zealand University Hospital Køge (DK)
- Technical University of Denmark (DK)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1371/journal.pone.0362695
- Primary Topic
- Otolaryngology and Infectious Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novo Nordisk
- Novo Nordisk Fonden